Identification of oncogenic driver mutations by genome-wide CRISPR-Cas9 dropout screening

被引：0
|
作者：
Michael K. Kiessling
Sven Schuierer
Silke Stertz
Martin Beibel
Sebastian Bergling
Judith Knehr
Walter Carbone
Cheryl de Vallière
Joelle Tchinda
Tewis Bouwmeester
Klaus Seuwen
Gerhard Rogler
Guglielmo Roma
机构：
[1] University Hospital Zürich,Department of Gastroenterology and Hepatology
[2] Novartis Institutes for Biomedical Research,Institute of Medical Virology
[3] Novartis Pharma AG,Department of Oncology
[4] University of Zürich,undefined
[5] Children University Hospital Zürich,undefined
来源：
BMC Genomics | / 17卷
关键词：
Whole genome CRISPR screen; Dropout; Negative selection; Driver mutations; EGFR; NRAS; Kinase;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Identification of Novel Regulatory Genes in APAP Induced Hepatocyte Toxicity by a Genome-Wide CRISPR-Cas9 Screen
    Katherine Shortt
    Daniel P. Heruth
    NiNi Zhang
    Weibin Wu
    Shipra Singh
    Ding-You Li
    Li Qin Zhang
    Gerald J. Wyckoff
    Lei S. Qi
    Craig A. Friesen
    Shui Qing Ye
    Scientific Reports, 9
  • [32] Genome-wide CRISPR-cas9 knockout screening identifies GRB7 as a driver for MEK inhibitor resistance in KRAS mutant colon cancer
    Yu, Chune
    Luo, Dan
    Yu, Jing
    Zhang, Min
    Zheng, Xiaobo
    Xu, Guangchao
    Wang, Jiaxin
    Wang, Huiling
    Xu, Yufei
    Jiang, Ke
    Xu, Jie
    Ma, Xuelei
    Jing, Jing
    Shi, Hubing
    ONCOGENE, 2022, 41 (02) : 191 - 203
  • [33] Genome-wide CRISPR-cas9 knockout screening identifies GRB7 as a driver for MEK inhibitor resistance in KRAS mutant colon cancer
    Chune Yu
    Dan Luo
    Jing Yu
    Min Zhang
    Xiaobo Zheng
    Guangchao Xu
    Jiaxin Wang
    Huiling Wang
    Yufei Xu
    Ke Jiang
    Jie Xu
    Xuelei Ma
    Jing Jing
    Hubing Shi
    Oncogene, 2022, 41 : 191 - 203
  • [34] Genome-wide CRISPR/Cas9 screening for drug resistance in tumors
    Zhang, Zhongyan
    Wang, Hailiang
    Yan, Qian
    Cui, Jinwei
    Chen, Yubin
    Ruan, Shiye
    Yang, Jiayu
    Wu, Zelong
    Han, Mingqian
    Huang, Shanzhou
    Zhou, Qi
    Zhang, Chuanzhao
    Hou, Baohua
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [35] CRISPR-Cas9-based genome-wide screening of Toxoplasma gondii
    Sidik, Saima M.
    Huet, Diego
    Lourido, Sebastian
    NATURE PROTOCOLS, 2018, 13 (02) : 307 - 323
  • [36] Identification of genes associated with pancreatic cancer metastasis by genome-wide CRISPR Cas9 screening
    Li, Youjia
    Feng, Huiyi
    Liu, Guangjie
    Wong, Chi Hin
    Li, Chi Han
    Chen, Yangchao
    CANCER RESEARCH, 2017, 77
  • [37] UNRAVELLING DRUG RESISTANCE AND SENSITIZATION TO PROTEASOME INHIBITORS USING GENOME-WIDE CRISPR-CAS9 KNOCKOUT SCREENING.
    Vlayen, Sophie
    Caruso, Marino
    De Keersmaecker, Kim
    Daelemans, Dirk
    Delforge, Michel
    EXPERIMENTAL HEMATOLOGY, 2023, 124 : S153 - S153
  • [38] Genome-wide CRISPR-Cas9 screening identifies ITGA8 responsible for abivertinib sensitivity in lung adenocarcinoma
    Li, Xuan-guang
    Zhu, Guang-sheng
    Cao, Pei-jun
    Huang, Hua
    Chen, Yu-hao
    Chen, Chen
    Chen, Pei-jie
    Wu, Di
    Ding, Chen
    Zhang, Zi-he
    Zhang, Rui-hao
    Hu, Zi-xuan
    Zhao, Wen-hao
    Liu, Ming-hui
    Li, Yong-wen
    Liu, Hong-yu
    Chen, Jun
    ACTA PHARMACOLOGICA SINICA, 2025,
  • [39] Genome-Wide CRISPR-Cas9 Screening Reveals a Role for TRAF2 in Resistance to IMiDs in Multiple Myeloma
    Liu, Jiye
    Zhou, Wenrong
    Xing, Lijie
    Lin, Liang
    Wen, Kenneth
    Tai, Yu-Tzu
    Hideshima, Teru
    Cang, Yong
    Anderson, Kenneth C.
    BLOOD, 2018, 132
  • [40] Genome-wide CRISPR-Cas9 Screening Identifies ITGA8 Responsible for Abivertinib Sensitivity in Lung Adenocarcinoma
    Li, X.
    Huang, H.
    Liu, H.
    Chen, J.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S654 - S655
12345